You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma
|
|---|---|
| Published in |
Retrovirology, August 2015
|
| DOI | 10.1186/1742-4690-12-s1-p21 |
| Authors |
Lee Ratner, JC Ramos, Ariela Noy, Stefan Barta, Samir Parikh, Adrienne Phillips, Richard Ambinder, Dan Rauch, John Harding, Hicham Baydoun, Xiaogang Cheng, Breanna Caruso, Steven Jacobson |
Mendeley readers
The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 1 | 33% |
| Student > Postgraduate | 1 | 33% |
| Student > Master | 1 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 3 | 100% |